LEVILIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	P7UV3L2H80
Record Status	`Validated (UNII)`
Record Version

Show entries

Name

Type

Language

LEVILIMAB

Official Name

English

BCD-089

Code

English

levilimab [INN]

Common Name

English

Levilimab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN MONOCLONAL BCD-089 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL BCD-089 .KAPPA.-CHAIN, DIMER

Common Name

English

Showing 1 to 5 of 5 entries

Show entries

Code System

Code

Type

Description

FDA UNII

P7UV3L2H80

PRIMARY

CAS

2035008-70-7

PRIMARY

NCI_THESAURUS

C173804

PRIMARY

INN

10905

PRIMARY

Showing 1 to 4 of 4 entries

Subunit 0

Subunit 1

Subunit 2

Subunit 3

Show entries

From	To
1_22	1_95
1_147	1_203
1_223	3_218
1_229	2_229
1_232	2_232

Showing 1 to 5 of 16 entries

Previous1 2 3 4Next

Glycosylation Type

MAMMALIAN

Show entries

Showing 1 to 2 of 2 entries

Show entries

Related Record

Type

Details


					156G191JXJ

INTERLEUKIN 6 RECEPTOR

TARGET -> INHIBITOR

Amount:

Showing 1 to 1 of 1 entries

Show entries

Related Record

Type

Details


					P7UV3L2H80

LEVILIMAB

ACTIVE MOIETY

Amount:

Showing 1 to 1 of 1 entries

Show entries

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL	ESTIMATED C6468H9958N1728O2030S40
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL	ESTIMATED 146000 Da (average)

Showing 1 to 2 of 2 entries